2022 preview: Expect a row over controversial Alzheimer's drug
New Scientist
DECEMBER 29, 2021
Whether the drug can actually treat the chief symptoms of the disease will be a point of contention in 2022 In 2021, the US approved the first drug designed to treat the cause of Alzheimer's, but the European Union rejected it.
Let's personalize your content